BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 18249325)

  • 1. Aprotinin reduces cardiac troponin I release and inhibits apoptosis of polymorphonuclear cells during off-pump coronary artery bypass surgery.
    Bert C; De Buck F; Sergeant P; Van Hemelrijck J; Kasran A; Van Duppen V; Ceuppens J; Meyns B; Delforge M; Wouters P
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):16-22. PubMed ID: 18249325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery.
    Türköz A; Ciğli A; But K; Sezgin N; Türköz R; Gülcan O; Ersoy MO
    J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):603-10. PubMed ID: 11688002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher levels of serum cytokines and myocardial tissue markers during on-pump versus off-pump coronary artery bypass surgery.
    Nesher N; Frolkis I; Vardi M; Sheinberg N; Bakir I; Caselman F; Pevni D; Ben-Gal Y; Sharony R; Bolotin G; Loberman D; Uretzky G; Weinbroum AA
    J Card Surg; 2006; 21(4):395-402. PubMed ID: 16846420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-pump, beating-heart coronary artery operations in high-risk patients: an acceptable trade-off?
    Perrault LP; Menasché P; Peynet J; Faris B; Bel A; de Chaumaray T; Gatecel C; Touchot B; Bloch G; Moalic JM
    Ann Thorac Surg; 1997 Nov; 64(5):1368-73. PubMed ID: 9386706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-pump coronary artery bypass attenuates transient hepatocellular damage after myocardial revascularization.
    Yamada T; Ochiai R; Takeda J; Kikuchi H; Ishibashi M; Watanabe K
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):603-7. PubMed ID: 16202893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aprotinin reduces myocardial injury in the off-pump coronary artery bypass grafting].
    Yang Y; Xiao F; Chen HY; Li Y; Shi ZH
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2061-3. PubMed ID: 14703417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression in markers for thrombin, platelet activation, and inflammation in cell saver versus systemic blood in patients undergoing on-pump coronary artery bypass graft surgery.
    Takayama H; Soltow LO; Aldea GS
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):519-23. PubMed ID: 17678777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of cardiac biochemical and inflammatory markers in patients on cardiopulmonary bypass undergoing coronary artery bypass grafting.
    Meng QH; Zhu S; Sohn N; Mycyk T; Shaw SA; Dalshaug G; Krahn J
    J Card Surg; 2008; 23(6):681-7. PubMed ID: 18778302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygenation and release of inflammatory mediators after off-pump compared with after on-pump coronary artery bypass surgery.
    Rasmussen BS; Laugesen H; Sollid J; Grønlund J; Rees SE; Toft E; Gjedsted J; Dethlefsen C; Tønnesen E
    Acta Anaesthesiol Scand; 2007 Oct; 51(9):1202-10. PubMed ID: 17850560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial.
    Li Y; Dong H; Chen M; Liu J; Yang L; Chen S; Xiong L
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):908-16. PubMed ID: 21868252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery.
    Durand M; Chavanon O; Tessier Y; Meyer C; Casez M; Bach V; Maitrasse B; Girardet P
    J Card Surg; 2006; 21(1):17-21. PubMed ID: 16426342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study.
    Wan IY; Arifi AA; Wan S; Yip JH; Sihoe AD; Thung KH; Wong EM; Yim AP
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1624-31. PubMed ID: 15173716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
    Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
    Casati V; Della Valle P; Benussi S; Franco A; Gerli C; Baili P; Alfieri O; D'Angelo A
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):83-91. PubMed ID: 15224025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The release of systemic inflammatory mediators is independent of cardiopulmonary bypass temperature.
    Rasmussen BS; Sollid J; Knudsen L; Christensen T; Toft E; Tønnesen E
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):191-6. PubMed ID: 17418730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-pump coronary surgery causes immediate release of myocardial damage markers.
    Karu I; Tähepõld P; Sulling TA; Alver M; Zilmer M; Starkopf J
    Asian Cardiovasc Thorac Ann; 2009 Oct; 17(5):494-9. PubMed ID: 19917792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.